The Correlation Between Serum Chemokines and Clinical Outcome in Patients with Advanced Biliary Tract Cancer
BACKGROUND: Biliary tract cancers (BTCs) are known to have a dismal prognosis. A number of chemokines play important roles in the progress of BTCs. However, the serum levels of chemokines in BTCs have not yet been explored. METHODS: The sera of healthy donors (n = 8) and patients with BTCs who were...
Main Authors: | Su Jin Lee, Jung Eun Kim, Seung Tae Kim, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Won Ki Kang, Young Suk Park, Ho Yeong Lim |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-04-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S193652331730431X |
Similar Items
-
Molecular Subgroup Analysis of Clinical Outcomes in a Phase 3 Study of Gemcitabine and Oxaliplatin with or without Erlotinib in Advanced Biliary Tract Cancer
by: Seung Tae Kim, et al.
Published: (2015-02-01) -
The efficacy of immune checkpoint inhibitors in biliary tract cancer with KRAS mutation
by: Sun Young Jeong, et al.
Published: (2023-05-01) -
Genomic Alterations in Biliary Tract Cancer Using Targeted Sequencing
by: Kwai Han Yoo, et al.
Published: (2016-06-01) -
Triptolide as a novel agent in pancreatic cancer: the validation using patient derived pancreatic tumor cell line
by: Seung Tae Kim, et al.
Published: (2018-11-01) -
gene amplification in patients with metastatic cancer
by: Su Jin Lee, et al.
Published: (2017-09-01)